10 December 2018 - Americans are generally uncomfortable with pharmaceutical prices — which are the highest for brand drugs among wealthy nations — and with drug companies’ profits. 

But if policies were adopted to reduce drug prices, could there be negative consequences? On balance, would such policies be good or bad?

I asked three health policy experts to consider these questions in the context of four specific drug pricing policies.

Read New York Times article